(Note: Some of these states have limited hemp programs or low-THC CBD allowances, but none have mandatory product testing for adult-use or full-spectrum medical cannabis.)
Not required.
These states have no legalized medical or adult-use cannabis programs at the state level. Therefore, there is no requirement for cannabis testing, and no framework exists for issuing or verifying Certificates of Analysis (COAs) for consumer products.
Not required.
No cannabinoid testing is mandated. Products sold within these states, whether via unregulated markets, hemp-derived cannabinoids, or online, are not subject to potency verification or cannabinoid profiling by state-authorized labs.
Not required.
There are no requirements for terpene testing or labeling.
Not required.
There are no testing mandates for contaminants such as:
Products may be sold or marketed without any laboratory verification.
These states do not enforce limits or conduct oversight for the following high-risk substances in cannabis or hemp-derived products:
High Concern:
Products sold in these states, especially online or via gray-market delta-8/delta-10 channels, are not subject to standardized testing or enforcement. Consumers have no assurance of product safety or potency, and contaminated or mislabeled products may enter the market without detection.
Not required.
No state-mandated limits for water activity (aw) or moisture content apply.
None.
These states do not have a cannabis regulatory agency because they have not legalized cannabis in any form beyond federally permitted hemp. Some may regulate hemp-derived products or delta-8 THC through agriculture or consumer protection agencies, but testing is often voluntary or limited to labeling enforcement.
Cannabis Cate
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.